ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269719 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269719; 2) Community: the network communities that were significantly associated with the response to NSC 269719; 3) Molecule: the relationships between components within communities and NSC 269719; 4) MDR: the compounds that were significantly associated with the NSC 269719.

NSC Compound Enrichment Correlation
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.012942183459279 0.16317397
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.012942183459279 0.1418911
NSC 750050 Null 0.012942183459279 0.1418197
NSC 755442 Null 0.012942183459279 0.21416231
NSC 756375 GW811761X 0.012942183459279 0.1044032
NSC 756483 SB-742864 0.012942183459279 -0.010071899
NSC 93819 Depakine 0.012942183459279 0.075387581
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0133012546828912 0.083334644
NSC 348402 Null 0.0133012546828914 0.1232952
NSC 408200 Null 0.0133012546828914 0.39431419
Total:61  Current:17    [First] [Prev] [Next] [Last]